Prospective randomised controlled trial to compare safety and efficacy of intravaginal Misoprostol with intracervical Cerviprime for induction of labour with unfavourable cervix

Journal of Obstetrics and Gynaecology

Volumn 28, Issue 3, 2008, Pages 294-297

  Krithika, K S ^a   Aggarwal, N ^a   Suri, V ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Cerviprime; Induction of labour; Misoprostol

Indexed keywords

MISOPROSTOL; OXYTOCIN; PROSTAGLANDIN E2; TERBUTALINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; GESTATIONAL AGE; HEART RATE; HUMAN; HYPERSTIMULATION; LABOR INDUCTION; MAJOR CLINICAL STUDY; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOLUTIO PLACENTAE; TREATMENT OUTCOME; UTERINE CERVIX DISEASE;

ADMINISTRATION, INTRAVAGINAL; ADULT; CERVICAL RIPENING; CERVIX UTERI; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GELS; HUMANS; LABOR, INDUCED; MISOPROSTOL; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, THIRD; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME;

EID: 45749134663     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610802054972     Document Type: Article

References (13)

1. Agarwal N, Gupta A, Kriplani A, Bhatla N and Parul. 2003. Six hourly vaginal Misoprostol versus intracervical Dinoprostone for cervical ripening and labour induction. Journal of Obstetrics and Gynaecology Research 29:147.
2. Brindley BA, Sokol RJ. 1988. Induction and augmentation of labor: Basis and methods for current practice. Obstetrics and Gynecology Surveys 43:730-743.
3. Buser D, Mira G, Arias F. 1997. A randomized comparison between Misoprostol and Dinoprostone for cervical ripening and labor induction in patients with unfavorable cervices. Obstetrics and Gynecology 89:581-585.
4. Cecatti JG, Tedesco RP, Pires HM, Calderon IM, Faundes A. 2006. Effectiveness and safety of a new vaginal Misoprostol product specifically labeled for cervical ripening and labor induction. Acta Obstetricia et Gynecologica et Scandinavica 85:706-711.
5. Hofmeyr GJ, Gulmezoglu AM. 2003. Vaginal Misoprostol for cervical ripening and induction of labor. Cochrane Database Systematic Review CD 000941.
6. Hofmeyr GJ. 2001 Vaginal misoprotol for cervical ripening and labor induction in late pregnancy (Cochrane review). In: The Cochrane Library. Issue 2. Oxford: Update Software.
7. Sanchez-Ramos L, Kaunitz AM, Gerardo O, Del Valle, Delke I, Schroeder PA. 1993. Labor induction with the prostaglandin E1 methyl analogue Misoprostol versus oxytocin. A randomized trial. Obstetrics and Gynecology 81:332-336.
8. Sanchez-Ramos L, Kaunitz AM, Wears RL et al. 1997. Misoprostol for cervical ripening and labor induction. A meta-analysis. Obstetrics and Gynecology 89:633-642.
9. Sanchez- Ramos L, Kaunitz AM. 2000. Misoprostol for cervical ripening and labor induction. A systematic review of the literature. Clinics in Obstetrics and Gynecology 43:475-488.
10. Varaklis K, Gumina R, Stubb PG. 1995. Randomized controlled trial of vaginal Misoprostol and intracervical prostaglandin E2 gel for induction of labor at term. Obstetrics and Gynecology 86:541-544.
11. Wing DA. 2002. A benefit-risk assessment of Misoprostol for cervical ripening and labor induction. Drug Safety 25:665-676.
12. Wing DA, Jones MM, Rahal A, Goodwin TM, Paul RH. 1995. A comparison of Misoprostol and prostaglandin E2 gel for preinduction cervical ripening and labor induction. American Journal of Obstetrics and Gynecology 172:1804-1810.
13. Wing DA, Paul RH. 1996. A comparison of different dosing regimens of vaginally administered Misoprostol for preinduction cervical ripening and labor induction. American Journal of Obstetrics and Gynecology 175:158-164.